SCHEMBL2188653

SCHEMBL2188653

COc1cc2nc(N3CCC(Cc4ccccc4)(C(=O)NCc4cccnc4)CC3)nc(N)c2cc1OC.COc1cc2nc(N3CCC(Cc4ccccc4)(C(=O)NCc4cccnc4)CC3)nc(O)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 5/20 0.49
ADRA1B P35368 5/20 0.49
KDM4E B2RXH2 3/20 0.48
GLA P06280 3/20 0.48
GAA P10253 3/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
CYP3A4 P08684 2/20 0.48
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
ADRA2B P18089 2/20 0.48
ADRA2C P18825 2/20 0.48
OPRM1 P35372 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
SLC22A2 O15244 1/20 0.48
SLC22A1 O15245 1/20 0.48
ABCC4 O15439 1/20 0.48
SLC22A3 O75751 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2170425 0.96 ADRA1A (0.52) ADRA1AADRA1BKDM4EGLAGAA
SCHEMBL2170268 0.96 PDGFRB (0.45) ADRA1AADRA1BKDM4EALDH1A1MAPT
SCHEMBL2170869 0.90 ADRA1A (0.57) ADRA1AADRA1BKDM4EGLAGAA
SCHEMBL2170380 0.89 WHR1 (0.47) ADRA1AADRA1BKDM4EGLAGAA
SCHEMBL7918343 0.87 ADRA1A (0.55) ADRA1AADRA1BKDM4EGLAGAA
SCHEMBL2171759 0.86 ADRA1A (0.53) ADRA1AADRA1BKDM4EGLAGAA
SCHEMBL3321657 0.86 ADRA1A (0.53) ADRA1AADRA1BKDM4EGLAGAA
SCHEMBL13333037 0.85 ADRA1A (0.51) ADRA1AADRA1BKDM4EGLAGAA
SCHEMBL14715512 0.85 ADRA1A (0.51) ADRA1AADRA1B
SCHEMBL3319263 0.84 ADRA1A (0.52) ADRA1AADRA1BKDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346848-A1 QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2011-07-27 EP claimed